{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "20220694",
  "DateCompleted": {
    "Year": "2010",
    "Month": "05",
    "Day": "17"
  },
  "DateRevised": {
    "Year": "2016",
    "Month": "11",
    "Day": "25"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "1750-8460",
      "JournalIssue": {
        "Volume": "71",
        "Issue": "2",
        "PubDate": {
          "Year": "2010",
          "Month": "Feb"
        }
      },
      "Title": "British journal of hospital medicine (London, England : 2005)",
      "ISOAbbreviation": "Br J Hosp Med (Lond)"
    },
    "ArticleTitle": "Amyloid heart disease.",
    "Pagination": {
      "StartPage": "76",
      "EndPage": "82",
      "MedlinePgn": "76-82"
    },
    "Abstract": {
      "AbstractText": [
        "Heart involvement can have devastating consequences. The clinical consequences will depend on the type of amyloid, the extent of systemic involvement and treatment options. Patients in whom disease recognition is late have poor outcomes, because of the severity of cardiac compromise and the necessarily aggressive treatments."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Cardiology, Hillingdon Hospital, Uxbridge Middlesex."
          }
        ],
        "LastName": "Dubrey",
        "ForeName": "Simon W",
        "Initials": "SW"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Falk",
        "ForeName": "Rodney H",
        "Initials": "RH"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Br J Hosp Med (Lond)",
    "NlmUniqueID": "101257109",
    "ISSNLinking": "1750-8460"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Amyloid"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Prealbumin"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Amyloid"
    },
    {
      "QualifierName": [
        "diagnostic imaging",
        "therapy"
      ],
      "DescriptorName": "Amyloidosis"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Epidemiologic Methods"
    },
    {
      "QualifierName": [
        "diagnostic imaging",
        "therapy"
      ],
      "DescriptorName": "Heart Diseases"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Heart Transplantation"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Prealbumin"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Prognosis"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Risk Factors"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Stem Cell Transplantation"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Time Factors"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Ultrasonography"
    }
  ]
}